PF-06873600

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-06873600, covering 2024-07-31 to 2024-07-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study of PF-06873600 in People With Cancer [Phase 1, Phase 2]